Viewing Study NCT06940518


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2026-01-26 @ 11:29 PM
Study NCT ID: NCT06940518
Status: RECRUITING
Last Update Posted: 2025-08-17
First Post: 2025-04-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma
Sponsor:
Organization: